A program providing fruit and vegetable prescriptions for diabetes management

A Pilot, 3-arm Randomized Controlled Trial of a Fruit and Vegetable Prescription Program for Patients With Type Two Diabetes

Not applicable Interventional Milton S. Hershey Medical Center · NCT06107816

This study is testing whether giving low-income Hispanic adults with Type 2 diabetes vouchers for fruits and vegetables, along with diabetes education, can help them manage their condition better.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment120 (estimated)
Ages18 Years and up
SexAll
SponsorMilton S. Hershey Medical Center Academic / other
Locations1 site (Reading, Pennsylvania)
Trial IDNCT06107816 on ClinicalTrials.gov

What this trial studies

This program aims to improve diabetes management among Hispanic adults by providing vouchers for fruits and vegetables (F&V) through a prescription model. It targets patients with Type 2 Diabetes Mellitus (T2DM) who are low-income and have not previously engaged in diabetes self-management education. The intervention includes usual care, F&V prescriptions alone, and F&V prescriptions combined with diabetes self-management education and support (DSME/S). The study will assess the impact on dietary intake, glucose control, and program implementation outcomes.

Who should consider this trial

Good fit: Ideal candidates are low-income Hispanic adults diagnosed with Type 2 Diabetes Mellitus for at least six months and with an A1c level of 7% or higher.

Not a fit: Patients who have recently participated in similar programs or who have uncontrolled mental illness or substance abuse issues may not benefit from this study.

Why it matters

Potential benefit: If successful, this program could significantly improve dietary habits and glucose control in patients with Type 2 Diabetes Mellitus.

How similar studies have performed: Preliminary studies of similar F&V prescription programs have shown positive outcomes, including increased fruit and vegetable intake and reductions in hemoglobin A1c levels.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient at Penn State Health St. Joe's Medical Center
* Diagnosis of Type 2 Diabetes Mellitus greater than or equal to six months
* A1c level is greater than or equal to 7% (53 mmol/mol)
* Low income defined as enrolled in Supplemental Nutrition Assistance Program (SNAP), is uninsured or have Medicaid, or identifying as food insecure based on USDA criteria.
* Ability to give a blood sample
* Willing to respond to contacts from study staff over the study period
* Willing and able to give informed consent
* Can read and write in English or Spanish

Exclusion Criteria:

* Diagnosis of Type 2 Diabetes Mellitus less than six months
* Patients who have previously participated in the Veggie Rx program in the past year
* Patients who have attended any diabetes self-management education and support (DSME/S) sessions in the past year
* Women who are pregnant or who plan to become pregnant during the study period
* Any uncontrolled mental illness or substance abuse, or inpatient treatment for these in the past six months
* Any unstable or significant medical condition in the past 3 months (e.g. recent heart attack, stroke, DVT)
* A1c level is less than 7%
* Does not speak English or Spanish
* Inability to provide informed consent
* Unable to give a blood sample

Where this trial is running

Reading, Pennsylvania

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Diabetes MellitusDiabetes Complications
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.